METTL3 and breast cancer: METTL3 knockdown cells exhibited a significant defect in proliferation, which was accentuated in the breast cancer cell lines MCF7 and MDA-MB-231 compared to METTL3 knockdowns in MCF10-A (Fig. 2F–H).